Skip to main content

IDH2 Gene Mutation clinical trials at UCSF

2 in progress, 1 open to eligible people

The IDH2 gene mutation changes how cells grow and divide. UCSF is conducting trials to test the effects of BGB-290 and temozolomide on brain tumors with this mutation. The study aims to identify the safest and most effective doses for young and adult patients.

Showing trials for

Our lead scientists for IDH2 Gene Mutation research studies include .

Last updated: